-
Healthstate Utilities for Hormone Receptor-Positive (HR+) Human Epidermal Growth Factor-Receptor 2 Negative (HER2-) Breast Cancer
Sep 9, 2025, 16:22 PM -
Mapping the Rare Disease Diagnostic Odyssey of Today: An Adapted Targeted Literature Review (ATLR)
Sep 9, 2025, 16:22 PM -
Digital Therapeutics in Europe: A Structured Review of Reimbursement and Access Pathways
Sep 9, 2025, 16:22 PM -
The Ongoing Challenge of Clostridioides Difficile Infection in Austria: Economic Evaluation of Two Recommended Treatment Pathways
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Contemporary First-Line (1L) Treatments for Locally Advanced or Metastatic Urothelial Carcinoma La/mUC in France: A Sensitivity Analysis
Sep 9, 2025, 16:22 PM -
Concordance Between Patient and Physician Reporting of Symptoms for Metastatic Urothelial Cancer in Europe: A Real-World Survey
Sep 9, 2025, 16:22 PM -
What Did Time Reveal Evaluating the Accuracy of Parametric Model Predictions Against Long-Term Observed Data for Larotrectinib?
Sep 9, 2025, 16:22 PM -
Assessing the Clinical and Economic Burden of Surgical Bleeding in Switzerland
Sep 9, 2025, 16:22 PM -
Spain Leveling Up: A Comparison of Spain’s New National Health Economic Evaluation Guideline With Those of England, France, Germany, Italy, Portugal, Sweden, Ireland, Canada, Australia, and Japan
Sep 9, 2025, 16:22 PM -
A Transitional Reimbursement Mechanism for New Medicinal Products Addressing High Unmet Clinical Need in Greece: Proposal for a Medicines Innovation Fund
Sep 9, 2025, 16:22 PM -
Durable Medical Equipment and Ancillary Service Use in Rett Syndrome Management: A Global Comprehensive Review of Literature
Sep 9, 2025, 16:22 PM -
Assessing the Psychometric Performance of the Experimental EQ-TIPS V20 in Assessing the Health-Related Quality of Life of Stunted Children in Laos
Sep 9, 2025, 16:22 PM -
Patient Access Delays for Subsequent Indications of Multi-indication Treatments: An Assessment of Health Technology Assessment Decision Making
Sep 9, 2025, 16:22 PM -
Assessing the Value of the Enzyme Replacement Therapy for Hypophosphatasia (HPP): A Spanish Subanalysis of a Pan-European Multidisciplinary Multicriteria Decision Analysis (MCDA)
Sep 9, 2025, 16:22 PM -
Assessing Different Procurement Models for Automated Insulin Delivery (AID) Systems Using a Multicriteria Decision Analysis (MCDA)-Based Framework
Sep 9, 2025, 16:22 PM -
Patient-Centered PICO Scoping in EU HTA: A Pilot Study for Structured Consensus Building Using a Delphi Panel
Sep 9, 2025, 16:22 PM -
Costs and Health Outcomes of Meek Skin Micrografting vs. Mesh Skin Grafting in Adult Patients With Deep Partial Thickness and/or Full-Thickness Small (Burn) Wounds
Sep 9, 2025, 16:22 PM -
National Competent Authorities’ Experiences With Early Feasibility Study Assessment: Promoting Dialogue, Supporting Sponsors, and Fostering Shared Learning to Harmonize the EU Framework
Sep 9, 2025, 16:22 PM -
Vignette-Based Economic Models in UK HTA Submissions: Valuable Tool or Just NICE in Theory?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer Alongside the LIBELULE Randomized Phase III Trial
Sep 9, 2025, 16:22 PM
